Research & Development

Our R&D Program: animal model studies for autism (ASD) and epilepsy, analytical chemistry and separation methods, and our most promising studies with biosynthesis of minor cannabinoids, and monoclonal antibodies (mAb) targeting Alzheimer (AD).

Research & Development

Our R&D Program: animal model studies for autism (ASD) and epilepsy, analytical chemistry and separation methods, and our most promising studies with biosynthesis of minor cannabinoids, and monoclonal antibodies (mAb) targeting Alzheimer (AD).

R&D PROGRAM

Research are led by our Scientific Committee including collaborations with:
  • Universidade de Aveiro - Portugal
  • Biocant - Cantanhede Portugal
  • Biotech - San Diego California
  • Brain Institute at the UFRN University (Brazil) , the largest neurosciences institute in Latin America.

Under the supervision of our Scientific Director Elmo Resende, PhD

R&D PROGRAM

Research are led by our Scientific Committee including collaborations with:
  • Universidade de Aveiro - Portugal
  • Biocant - Cantanhede Portugal
  • Biotech - San Diego California
  • Brain Institute at the UFRN University (Brazil) , the largest neurosciences institute in Latin America.

Under the supervision of our Scientific Director Elmo Resende, PhD

MEDICAL APPLICATIONS

Our innovative approach, backed by pioneering research in the field, is the essence of the vision of our company and projects.We aim to produce and procure high-grade medical cannabis oils and capsules that contain a highly sought-after combination of cannabinoids for the treatment of various diseases. And throughout the process we adopt proper procedures for seed selection, plant production, extraction processes and production of standardized medicines.

MEDICAL APPLICATIONS

Our innovative approach, backed by pioneering research in the field, is the essence of the vision of our company and projects.We aim to produce and procure high-grade medical cannabis oils and capsules that contain a highly sought-after combination of cannabinoids for the treatment of various diseases. And throughout the process we adopt proper procedures for seed selection, plant production, extraction processes and production of standardized medicines.

Invest in Piauhy

The Medical Cannabis company of the future

Piauhy is a multinational biotech pharma company that is patient's driven and focused on high end EU GMP Pharma Certified medicinal cannabis products.

Invest today

Commercial Alliance

Let's grow together

We can support your commercial needs all over the world, contact us to know about our products and services and to leverage your market opportunities.

Get in touch

Invest in Piauhy

The Medical Cannabis company of the future

Piauhy is a multinational biotech pharma company that is patient's driven and focused on high end EU GMP Pharma Certified medicinal cannabis products.

Invest today

Commercial Alliance

Let's grow together

We can support your commercial needs all over the world, contact us to know about our products and services and to leverage your market opportunities.

Get in touch

OUR ECOSYSTEM

 
 
Investor